UNP
40
2
INTU
57
3
CRM
67
2
ROK
48
2
JBHT
48
2
NEE
44
3
BEN
40
3
SPG
50
4
TXN
35
5
SIG
55
3
STI
35
14
SYF
83
7
STT
64
5
SNA
58
2
MS
70
6
CMS
60
2
PRU
47
2
SLB
45
4
VTR
46
3
BLK
54
4
UNP
40
2
INTU
57
3
CRM
67
2
ROK
48
2
JBHT
48
2
NEE
44
3
BEN
40
3
SPG
50
4
TXN
35
5
SIG
55
3
STI
35
14
SYF
83
7
STT
64
5
SNA
58
2
MS
70
6
CMS
60
2
PRU
47
2
SLB
45
4
VTR
46
3
BLK
54
4
Financhill
Back

Crinetics Pharmaceuticals 10K Form

Sell
30

CRNX
Crinetics Pharmaceuticals

Last Price:
$53.35
Seasonality Move:
-9.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRNX News And Ratings

See the #1 stock for the next 7 days that we like better than CRNX

CRNX Financial Statistics

Sales & Book Value

Annual Sales: $4M
Cash Flow: $-63.4M
Price / Cash Flow: 0
Annual Sales: $10.30
Price / Book: 6.01

Profitability

EPS (TTM): -3.73000
Net Income (TTM): $-277.9M
Gross Margin: --
Return on Equity: -42.43%
Return on Assets: -37.11%

Crinetics Pharmaceuticals Earnings Forecast

Key Crinetics Pharmaceuticals Financial Ratios

  • The Research & Development expenses have been 4,199.53% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CRNX is -5,345.85% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Crinetics Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRNX
CUSIP: 22663K
Website: crinetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 16.09
Quick Ratio: 15.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRNX Technical Analysis vs Fundamental Analysis

Sell
30
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy or a Sell?